On Wednesday, JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO)’s shares inclined -0.39% to $7.76.
JA Solar Holdings Co., Ltd. (ADR) (JASO) declared its standard modules successfully passed the Class A fire test in accordance with UL1703 standard for Type 1 modules. During the test, all six sets of BOM used for JA Solar’s type-1 modules passed the UL Class A fire test conducted by Intertek, making JA Solar the first company mass producing PV modules in China to pass the test.
In recent years, as the installation of solar electricity generation has been rapidly grown worldwide at a unprecedented pace, the standard and criteria for the reliability certification of PV module s have been constantly updated and expande d i n order to meet the increasing demand for PV products with better quality and higher reliability from the end user of solar electricity, in addition to the more stringent s afety, environment, and hazard regulations for PV installation s b y l egislatures and governments at various levels.
JA Solar Holdings Co., Ltd., together with its auxiliaries, designs, develops, manufactures, and sells photovoltaic solar cells and solar power products based on crystalline silicon technologies. The company’s principal products comprise monocrystalline and multicrystalline solar cells and modules. It also provides monocrystalline and multicrystalline silicon wafers; solar product processing services; and engineering, procurement, and construction services to independent power project developers and public utility companies.
SLM Corp (NASDAQ:SLM)’s shares dropped -0.20% to $9.74.
Sallie Mae (SLM), the nation’s saving, planning and paying for College Company, declared a 2015 third-quarter dividend on its Preferred Stock Series A of 6.97 percent, or $0.87125 per share. The dividend will be paid on July 30, 2015, to stockholders of record at the close of business on July 20, 2015.
On March 31, 2015, Sallie Mae had about 3.3 million shares of Preferred Stock Series A outstanding.
SLM Corporation, together with its auxiliaries, operates as a saving, planning, and paying for education company in the United States. The company offers private education loans to students and their families. It also provides banking products, such as high yield savings accounts, money market accounts, and certificates of deposits; and operates a consumer savings network that offers financial rewards on everyday purchases to assist families save for college. SLM Corporation was founded in 1972 and is headquartered in Newark, Delaware.
At the end of Wednesday’s trade, Under Armour Inc (NYSE:UA)‘s shares dipped -0.59% to $88.28.
Under Armour, Inc. (UA) will report the results of its second quarter ended June 30, 2015 on Thursday, July 23, 2015 at 7:15 a.m. ET. Under Armour administration will host a conference call to talk about the results starting at 8:30 a.m. ET. This call will be webcast live at http://investor.underarmour.com/events.cfm and will be archived and accessible for replay about three hours after the live event.
Under Armour, Inc., together with its auxiliaries, develops, markets, and distributes branded performance apparel, footwear, and accessories for men, women, and youth primarily in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company offers its apparel in compression, fitted, and loose types to be worn in hot, cold, and in between the extremes. It offers various footwear products, counting football, baseball, lacrosse, softball and soccer cleats, slides, performance training, running, basketball, and outdoor footwear.
MacroGenics Inc (NASDAQ:MGNX), ended its Wednesday’s trading session with -4.49% loss, and closed at $36.36.
MacroGenics, Inc. (MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, in addition to autoimmune disorders and infectious diseases, declared the pricing of an underwritten public offering of 3,525,000 shares of its common stock at a public offering price of $37.00 per share, before underwriting discounts. In addition, MacroGenics has granted the underwriters a 30-day option to purchase up to an additional 528,750 shares of common stock.
Morgan Stanley, Citigroup and Leerink Partners are acting as joint book-running managers of the projected offering. Stifel is acting as lead manager, and Wedbush PacGrow and Roth Capital Partners are acting as co-managers. The offering is predictable to close on or about July 20, 2015, subject to customary closing conditions.
MacroGenics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, in addition to autoimmune disorders and infectious diseases. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody-based technology platforms.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
